Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
1Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
Tyra Biosciences, Inc. (TYRA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
10Total relationships
1Distinct source URLs
9High confidence
0.842Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Tyra Biosciences, Inc. Suppliers
Ticker
Name
Confidence
Evidence
CONTRACT-RESEARCH-ORGANIZATIONS
CONTRACT-RESEARCH-ORGANIZATIONS
90%
The Company enters into contracts in the normal course of business with contract research organizations in preparation for clinical trials
PROFESSIONAL-CONSULTANTS
PROFESSIONAL-CONSULTANTS
85%
The Company enters into contracts in the normal course of business with contract research organizations in preparation for clinical trials, professional consultants for expert advice and other vendor…
VENDORS
VENDORS
85%
The Company enters into contracts in the normal course of business with contract research organizations in preparation for clinical trials, professional consultants for expert advice and other vendor…
THIRD-PARTIES
THIRD-PARTIES
80%
expenses incurred in connection with the discovery and preclinical development of our product candidates, including under agreements with third parties, such as consultants and CROs
THIRD-PARTY-MANUFACTURERS
THIRD-PARTY-MANUFACTURERS
80%
the cost of manufacturing compounds for use in our preclinical studies, including under agreements with third parties, such as consultants and third-party manufacturers
Tyra Biosciences, Inc. Customers
Ticker
Name
Confidence
Evidence
USA-LLC
USA-LLC
62%
bilities, add operational and management information systems and hire additional personnel, expand and protect our intellectual property, establish marketing, sales, distribution and other commercial…
Tyra Biosciences, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
TYRA-DEBT
Debt stack $5.7M
90%
Market cache reports total debt of $5.7M.
TYRA-DEBT-13180
Warrants outstanding: 0.001
90%
xbrl warrant detail from xbrl 2024-10-18.
TYRA-DEBT-13181
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
Tyra Biosciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Tyra Biosciences, Inc..
Tyra Biosciences, Inc. Ownership
Holder
Name
Confidence
Evidence
TYRA-OWNER-RA-CAPITAL-MANAGEMENT-L-P
RA CAPITAL MANAGEMENT, L.P.
90%
13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 164 tracked holders.
Tyra Biosciences, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
